Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × Doxorubicin × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 39 Breast Neoplasms 27 Lymphoma 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Sarcoma 21 Hodgkin Disease 20 Burkitt Lymphoma 20 Triple Negative Breast Neoplasms 18 Lymphoma, Follicular 14 Lymphoma, B-Cell 13 Ovarian Neoplasms 11 Neoplasms 10 Lymphoma, Non-Hodgkin 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, T-Cell, Peripheral 8 Lymphoma, Mantle-Cell 8 Endometrial Neoplasms 8 Neoplasm Metastasis 6 Multiple Myeloma 6 Lymphoma, B-Cell, Marginal Zone 6 Liposarcoma 6 Leukemia 6 Recurrence 5 Osteosarcoma 5 Neuroblastoma 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Leiomyosarcoma 5 Fallopian Tube Neoplasms 5 Urinary Bladder Neoplasms 4 Sarcoma, Ewing 4

Interventions

Gemcitabine 17 Mitomycin 9 Docetaxel 6 erdafitinib 5 dodecyl maltoside 4 Cystoscopy 4 BCG Vaccine 4 durvalumab 2 Radiotherapy 2 ALT-803 2 5-aminolevulinic acid hexyl ester 2 viscum album peptide 1 toripalimab 1 pirarubicin 1 pemigatinib 1 monalizumab 1 hydroxycamptothecinum 1 enfortumab vedotin 1 bicalutamide 1 Urine Specimen Collection 1 Transurethral Resection of Bladder 1 Surveys and Questionnaires 1 Patient Discharge 1 Paclitaxel 1 Nonsteroidal Anti-Androgens 1 Mitozytrex 1 Maintenance 1 Magnetic Resonance Spectroscopy 1 Injections 1 Imiquimod 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡